20259063 Stock Overview
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Coloplast A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.109.67 |
52 Week High | kr.143.26 |
52 Week Low | kr.102.98 |
Beta | 0.24 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -4.64% |
3 Year Change | -0.17% |
5 Year Change | 41.23% |
Change since IPO | 33.34% |
Recent News & Updates
Recent updates
Shareholder Returns
20259063 | CH Medical Equipment | CH Market | |
---|---|---|---|
7D | 0% | 0.5% | 0.8% |
1Y | -4.6% | 15.8% | 3.3% |
Return vs Industry: 020259063 underperformed the Swiss Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: 020259063 underperformed the Swiss Market which returned -0.9% over the past year.
Price Volatility
20259063 volatility | |
---|---|
20259063 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 3.7% |
Market Average Movement | 3.4% |
10% most volatile stocks in CH Market | 7.7% |
10% least volatile stocks in CH Market | 1.8% |
Stable Share Price: 020259063 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 020259063's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1954 | 14,572 | Kristian Villumsen | https://www.coloplast.com |
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
20259063 fundamental statistics | |
---|---|
Market cap | CHF24.53b |
Earnings (TTM) | CHF622.66m |
Revenue (TTM) | CHF2.99b |
39.4x
P/E Ratio8.2x
P/S RatioIs 20259063 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
20259063 income statement (TTM) | |
---|---|
Revenue | kr.22.58b |
Cost of Revenue | kr.7.05b |
Gross Profit | kr.15.53b |
Other Expenses | kr.10.82b |
Earnings | kr.4.71b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 03, 2023
Earnings per share (EPS) | 22.17 |
Gross Margin | 68.78% |
Net Profit Margin | 20.84% |
Debt/Equity Ratio | 217.1% |
How did 20259063 perform over the long term?
See historical performance and comparison